John Goll's most recent trade in Immunocore Holdings plc - ADR was a trade of 14,802 Employee Share Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immunocore Holdings plc - ADR | John Goll | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 14,802 | 14,802 | - | - | Employee Share Option (Right to Buy) | |
Immunocore Holdings plc - ADR | John Goll | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 5,405 | 5,405 | - | - | Restricted Share Units | |
Immunocore Holdings plc - ADR | John Goll | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 4,930 | 4,930 | - | - | Employee Share Option (Right to Buy) |